Transculturalization of a Diabetes-Specific Nutrition Algorithm: Asian Application

被引:0
作者
Hsiu-Yueh Su
Man-Wo Tsang
Shih-Yi Huang
Jeffrey I. Mechanick
Wayne H-H. Sheu
Albert Marchetti
机构
[1] Taipei Medical University Hospital,Department of Dietetics
[2] Taipei Medical University,School of Nutrition and Health Sciences
[3] United Christian Hospital,Medical and Geriatric Department
[4] Taipei Medical University,School of Nutrition and Health Sciences
[5] Mount Sinai School of Medicine,Division of Endocrinology, Diabetes, and Bone Disease
[6] Taichung Veterans General Hospital,Division of Endocrinology and Metabolism, Department of Medicine
[7] National Yang-Ming Medical University,School of Medicine
[8] National Defense Medical Center,College of Medicine
[9] University of Medicine and Dentistry of New Jersey,Department of Preventive Medicine and Public Health
[10] Taichung Veterans General Hospital,Department of Medicine
来源
Current Diabetes Reports | 2012年 / 12卷
关键词
Asians; Diabetes; Diabetes-specific formula; Medical nutrition therapy;
D O I
暂无
中图分类号
学科分类号
摘要
The prevalence of type 2 diabetes (T2D) in Asia is growing at an alarming rate, posing significant clinical and economic risk to health care stakeholders. Commonly, Asian patients with T2D manifest a distinctive combination of characteristics that include earlier disease onset, distinct pathophysiology, syndrome of complications, and shorter life expectancy. Optimizing treatment outcomes for such patients requires a coordinated inclusive care plan and knowledgeable practitioners. Comprehensive management starts with medical nutrition therapy (MNT) in a broader lifestyle modification program. Implementing diabetes-specific MNT in Asia requires high-quality and transparent clinical practice guidelines (CPGs) that are regionally adapted for cultural, ethnic, and socioeconomic factors. Respected CPGs for nutrition and diabetes therapy are available from prestigious medical societies. For cost efficiency and effectiveness, health care authorities can select these CPGs for Asian implementation following abridgement and cultural adaptation that includes: defining nutrition therapy in meaningful ways, selecting lower cutoff values for healthy body mass indices and waist circumferences (WCs), identifying the dietary composition of MNT based on regional availability and preference, and expanding nutrition therapy for concomitant hypertension, dyslipidemia, overweight/obesity, and chronic kidney disease. An international task force of respected health care professionals has contributed to this process. To date, task force members have selected appropriate evidence-based CPGs and simplified them into an algorithm for diabetes-specific nutrition therapy. Following cultural adaptation, Asian and Asian-Indian versions of this algorithmic tool have emerged. The Asian version is presented in this report.
引用
收藏
页码:213 / 219
页数:6
相关论文
共 190 条
[1]  
Chang CH(2010)Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study Diabet Med. 27 636-643
[2]  
Shau WY(2004)Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care. 27 1047-1053
[3]  
Jiang YD(2009)Diabetes in Asia: epidemiology, risk factors, and pathophysiology JAMA 301 2129-2140
[4]  
Li HY(2006)Epidemic obesity and type 2 diabetes in Asia Lancet. 368 1681-1688
[5]  
Chang TJ(2011)Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring Diabetes Metab Res Rev 27 79-84
[6]  
Sheu WH(2002)Ethnic disparities in diabetic complications in an insured population JAMA. 287 2519-2527
[7]  
Wild S(2011)Justifying the high prevalence of microalbuminuria for type 2 diabetic patients in Taiwan with conditional probability approach–a DEMAND II study J Chin Med Assoc. 74 3-10
[8]  
Roglic G(2005)An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study Diabetologia. 48 17-26
[9]  
Green A(2001)Evidence-based guidelines: application to clinical practice Phys Ther. 81 1622-1628
[10]  
Sicree R(1999)Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines BMJ. 318 527-530